Status:
UNKNOWN
Intermittent Fasting Compared to Continuous Energy Restriction on Body Weight Loss
Lead Sponsor:
Armed Police Force Hospital, Nepal
Conditions:
Overweight and Obesity
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
Obesity remains a major public health challenge. Intermittent fasting continues to gain popularity compared to continuous energy restriction as a weight-loss approach for cardiometabolic health. Studi...
Detailed Description
Overweight and obesity remain a major chronic health problem globally. The development of overweight and obesity is associated with various comorbidities including cardiovascular disease (CVD), dyslip...
Eligibility Criteria
Inclusion
- Men and women aged 18 years or above with body mass index (BMI) \>25 kg/m2
- Those who give consent to participate in our intervention study
Exclusion
- Those who are pregnant women, lactating women, or planning to become pregnant during the course of study.
- Those who are severely ill or more than two comorbidities such as major psychiatric disorders, previous gastric surgery, haematological disorders, insomnia, acute excerabation of chronic obstructive pulmonary disease, asthma, respiratorty tract infections, and diabetes patients if treated with insulin or hypoglycemic agents.
- Those who have any plan to migrate from the study area for at least three months
- Use of anti-obesity drugs or other drugs affecting body weight
- Eating disorder, alcohol or drug abuse that could contribute to difficulties with study procedures
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04526847
Start Date
April 1 2023
End Date
October 1 2023
Last Update
March 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dev Ram Sunuwar
Kathmandu, Bagmati, Nepal, +977